Jay Parrish

Jay Parrish is an accomplished executive in the biotechnology sector, currently serving as the Chairman and CEO of Pretzel Therapeutics, where the focus is on developing treatments for mitochondrial dysfunction. Jay holds multiple leadership roles, including Venture Partner at ARCH Venture Partners, Chairman of the Board at Lilac Therapeutics, and Co-Founder and Board Member at Amplitude Therapeutics. Extensive advisory positions include strategic roles at Magnet Biomedicine, Orbital Therapeutics, and HI-Bio: A Biogen Company. Academic credentials include an MBA in Finance from the University of California, Berkeley, a PhD in Synthetic Organic Chemistry from the University of South Florida, and a BS in Chemistry from Emory University. Jay's business acumen and scientific background drive innovative solutions in healthcare and disease treatment.